Analysts who follow Seelos Therapeutics Inc (SEEL) on average expect it to rise 691.67% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns Seelos Therapeutics Inc an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating SEEL a Strong Buy today. Find out what this means to you and get the rest of the rankings on SEEL!